Oct 22, 2023 / 01:00PM GMT
Presentation Call
Oct 22, 2023 / 01:00PM GMT
=====================
Corporate Participants
=====================
* Jeff Boyle
Arvinas, Inc. - VP of IR
* John G. Houston
Arvinas, Inc. - Chairperson, CEO & President
* Ronald A. Peck
Arvinas, Inc. - Chief Medical Officer
=====================
Conference Call Participants
=====================
* Ashiq Alim Mubarack
Citigroup Inc., Research Division - U.S. Mid & Small-Cap Biotechnology Analyst
* Bradley Patrick Canino
Stifel, Nicolaus & Company, Incorporated, Research Division - Research Analyst
* Christopher Liu
Leerink Partners LLC, Research Division - Associate
* Derek Christian Archila
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
* Edward Andrew Tenthoff
Piper Sandler & Co., Research Division - MD & Senior Research Analyst
* Eliana Rachel Merle
UBS Investment Bank, Research Division - Analyst
* Michael Werner Schmidt
Guggenheim
Arvinas Inc
(NAS:ARVN)
$
24.96
0.48 (1.96%)
Market Cap: 1.71 Bil
Enterprise Value: 486.86 Mil
PE Ratio: 0
PB Ratio: 2.85
GF Score: 73/100 Arvinas Inc To Host ESMO Data Presentation Call Transcript
Oct 22, 2023 / 01:00PM GMT
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot